1-5 of 5
Hetalkumari Patel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Incidence of Invasive Fungal Infections in CAR T-Cell Therapy Recipients: A Single-Center Retrospective Analysis

Aishwarya Sannareddy, Laura Turer, Jimmy Lee, Kailee Gaines, Hetalkumari Patel, Pearl Abraham, Ashley Jones, Alicia Yn, Ebubechukwu Eze, Pearlie Chong, Jeffrey Tessier, Stephen S. Chung, Robert H. Collins, Yazan F. Madanat, Heather R Wolfe, Elif Yilmaz, Julio Alvarenga Thiebaud, Praveen Ramakrishnan Geethakumari, Gurbakhash Kaur, Adeel Khan, Larry D. Anderson, Jr., Farrukh T. Awan, Ricardo La Hoz, Aimaz Afrough
Journal: Blood
Blood (2023) 142 (Supplement 1): 6921.
https://doi.org/10.1182/blood-2023-186596
Published: 2023
Journal Articles

Do Monoclonal Antibody Therapies Improve 'Real-World' Outcomes of COVID-19 in Patients with Lymphoid Malignancies? the UT Southwestern Experience

Aishwarya Sannareddy, Heather Reves, Kefyalew Jaleta, Ramyakumari .Ramiahsankarasubramanian, Hetalkumari Patel, Madhusudhanan Narasimhan, Larry D. Anderson, Jr., Aimaz Afrough, Stephen S. Chung, Robert H. Collins, Gurbakhash Kaur, Kiran A Kumar, Yazan F. Madanat, Madhuri Vusirikala, Farrukh T. Awan, Alagarraju Muthukumar, Praveen Ramakrishnan Geethakumari
Journal: Blood
Blood (2022) 140 (Supplement 1): 5203–5205.
https://doi.org/10.1182/blood-2022-171001
Published: 2022
Journal Articles

Post-Transplant Cyclophosphamide Associated with Increased Early Mixed Donor Chimerism in Myeloid Malignancies; A Single-Center Experience

Fieke W. Hoff, Prapti A. Patel, Stephen S. Chung, Naveen Premnath, Jude Khatib, Mirjana Tadic-Ovcina, Abeer AhmedRabie, Debra Helton, Jaime Shahan, Courtney Dryden, Hetalkumari Patel, Afrough Aimaz, Praveen Ramakrishnan Geethakumari, Robert H. Collins, Madhuri Vusirikala, Yazan F. Madanat
Journal: Blood
Blood (2022) 140 (Supplement 1): 4749–4750.
https://doi.org/10.1182/blood-2022-166756
Published: 2022
Journal Articles

Time and Personnel Costs Associated with Adverse Event (AE) Management Among Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Acalabrutinib, Ibrutinib, or Venetoclax

Hetalkumari Patel, Svea K. Wahlstrom, Maral DerSarkissian, Colin Kunzweiler, Felicia Castriota, Rose Chang, Hoi Ching Cheung, Yuqian Gu, Helen Guo, Mei Sheng Duh, Kellie J. Ryan
Journal: Blood
Blood (2021) 138 (Supplement 1): 2999.
https://doi.org/10.1182/blood-2021-147449
Published: 2021
Journal Articles

Factors Associated with Clinical Outcomes after Venetoclax-Based Combination Therapy in Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

Yazan F. Madanat, MD, Hetalkumari Patel, PharmD, BCOP, Omik Patel, PharmD, BCOP, Jingsheng Yan, PhD, Jude Khatib, MD, Madhuri Vusirkala, MD, Suleyman Y Goksu, MD, Chul Ahn, PhD, Prapti A. Patel, MD, Robert H. Collins, MD, Stephen Chung, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43.
https://doi.org/10.1182/blood-2020-139794
Published: 2020